Naronaprle

N/A

Report date: 2024/01/26 17:06:07
NME

Base Information

Drug NameNaronaprle
Drug Alias NameNaronapride(Renexxion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonistsDopamine D2 receptor antagonists
TargetsSerotonin 4 (5-HT4) receptorDopamine D2 receptor
Therapy Area/IndicationsGastroparesisGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRenexxion LLC
China Registration ClassN/A

Develop Information

Active CompaniesDr Falk Pharma GmbHRenexxion LLC
Inactive CompaniesN/A
Active IndicationsGastroparesisGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG